GC Biopharma녹십자

GC Biopharma006280· Biotech & PharmaInitiation

GC Biopharma: Revenue near ₩2.0T, thin operating margin and net losses, shares at 1.2x book

GC Biopharma (KOSPI: 006280) closed at ₩128,100 on 2026-10-12, for a market cap of about ₩1.5T, with trailing revenue of ₩1.96T but a net loss of ₩49.9B. The model estimate is well above the share price, but the range between bear and bull cases is very wide.

Oct 13, 20260 views